Skip to main content

and
  1. No Access

    Article

    A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity

    Although small cell lung cancer (SCLC) is treated as a homogeneous disease, biopsies and preclinical models reveal heterogeneity in transcriptomes and morphology. SCLC subtypes were recently defined by neuroen...

    Kathryn L. Simpson, Ruth Stoney, Kristopher K. Frese, Nicole Simms in Nature Cancer (2020)

  2. No Access

    Article

    Easing anxiety in preparation for pediatric magnetic resonance imaging: a pilot study using animal-assisted therapy

    Children undergoing magnetic resonance imaging (MRI) can experience negative emotions both before and during their scan, causing them to move and often necessitating the use of procedural sedation. Several str...

    Manuela Perez, Claire Cuscaden, Joanne F. Somers, Nicole Simms in Pediatric Radiology (2019)

  3. Article

    Open Access

    Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin

    Precision medicine aims to tailor cancer therapies to target specific tumor-promoting aberrations. For tumors that lack actionable drivers, which occurs frequently in the clinic, extensive molecular characteri...

    Pedro Torres-Ayuso, Sudhakar Sahoo, Garry Ashton, Elvira An in npj Genomic Medicine (2018)

  4. Article

    Open Access

    Vasculogenic mimicry in small cell lung cancer

    Small cell lung cancer (SCLC) is characterized by prevalent circulating tumour cells (CTCs), early metastasis and poor prognosis. We show that SCLC patients (37/38) have rare CTC subpopulations co-expressing v...

    Stuart C. Williamson, Robert L. Metcalf, Francesca Trapani in Nature Communications (2016)